PEAK6
PRME icon

PEAK6’s Prime Medicine PRME Stock Holding History

PEAK6’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-246,900
Closed -$857K – 3193
2025
Q4 		$857K Sell
246,900
-6,500
-3% -$28.9K ﹤0.01% 1848
2025
Q3 		$1.4M Buy
+253,400
New +$1.03M ﹤0.01% 1684

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

PEAK6's PRME Position: Q2 2026 in Review

PEAK6 opened a new position in Prime Medicine (PRME) in Q2 2026: 208,057 shares worth $768K. The stake represents ﹤0.01% of the portfolio and ranks #1802 among its holdings. This is a return to the name: PEAK6 previously reported a position in PRME as recently as Q3 2025.

PEAK6 first reported a position in PRME in Q4 2024 and has held it in 3 quarters since. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • PEAK6 held 208,057 shares of Prime Medicine worth $768K as of Q2 2026.
  • Prime Medicine was a new PEAK6 position in Q2 2026.
  • Prime Medicine made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #1802 holding.
  • PEAK6 first reported a position in Prime Medicine in Q4 2024 and has held it in 3 quarters since.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.